A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Merck & Co., Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 236,426 shares of MRK stock, worth $23.5 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
236,426
Previous 244,694 3.38%
Holding current value
$23.5 Million
Previous $30.3 Million 11.37%
% of portfolio
0.14%
Previous 0.17%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $918,988 - $1.07 Million
-8,268 Reduced 3.38%
236,426 $26.8 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $4.15 Million - $4.46 Million
33,539 Added 15.88%
244,694 $30.3 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $23.9 Million - $27.9 Million
211,155 New
211,155 $27.2 Billion
Q4 2023

Aug 14, 2024

SELL
$100.18 - $109.02 $302,543 - $329,240
-3,020 Reduced 1.52%
195,836 $21.4 Billion
Q3 2023

Aug 14, 2024

SELL
$102.95 - $114.33 $283,524 - $314,864
-2,754 Reduced 1.37%
198,856 $20.5 Billion
Q2 2023

Aug 14, 2024

SELL
$108.61 - $118.38 $1.3 Million - $1.41 Million
-11,952 Reduced 5.6%
201,610 $23.3 Billion
Q1 2023

Aug 14, 2024

SELL
$102.94 - $114.86 $1.95 Million - $2.17 Million
-18,899 Reduced 8.13%
213,562 $22.7 Billion
Q4 2022

Aug 14, 2024

SELL
$87.44 - $112.11 $4.52 Million - $5.79 Million
-51,677 Reduced 18.19%
232,461 $25.8 Billion
Q3 2022

Aug 14, 2024

BUY
$84.53 - $94.96 $960,514 - $1.08 Million
11,363 Added 4.17%
284,138 $24.5 Billion
Q2 2022

Aug 14, 2024

SELL
$83.49 - $94.64 $4.84 Million - $5.48 Million
-57,948 Reduced 17.52%
272,775 $24.9 Billion
Q1 2022

Aug 14, 2024

BUY
$73.51 - $82.4 $6.32 Million - $7.09 Million
86,029 Added 35.16%
330,723 $27.1 Billion
Q4 2021

Aug 30, 2024

SELL
$72.28 - $90.54 $1,301 - $1,629
-18 Reduced 0.01%
257,192 $19.7 Billion
Q3 2021

Aug 30, 2024

BUY
$71.68 - $78.83 $864,317 - $950,532
12,058 Added 4.92%
257,210 $19.3 Billion
Q2 2021

Aug 30, 2024

BUY
$70.31 - $77.77 $32,201 - $35,618
458 Added 0.19%
245,152 $19.1 Billion
Q1 2021

Aug 30, 2024

SELL
$68.86 - $81.11 $3.42 Million - $4.03 Million
-49,631 Reduced 16.77%
246,263 $19 Billion
Q4 2020

Aug 30, 2024

BUY
$71.77 - $79.65 $2.5 Million - $2.78 Million
34,881 Added 13.36%
295,894 $24.2 Billion
Q3 2020

Aug 30, 2024

SELL
$73.18 - $82.95 $1.24 Million - $1.4 Million
-16,887 Reduced 6.08%
261,013 $21.7 Billion
Q2 2020

Aug 30, 2024

BUY
$70.42 - $80.13 $3.73 Million - $4.25 Million
53,017 Added 23.58%
277,900 $21.5 Billion
Q1 2020

Aug 30, 2024

BUY
$63.36 - $87.82 $6.29 Million - $8.71 Million
99,216 Added 78.95%
224,883 $17.4 Billion
Q4 2019

Aug 30, 2024

SELL
$77.58 - $87.54 $317,690 - $358,476
-4,095 Reduced 3.16%
125,667 $11.4 Billion
Q3 2019

Aug 30, 2024

SELL
$76.08 - $82.93 $314,210 - $342,500
-4,130 Reduced 3.08%
129,762 $10.9 Billion
Q2 2019

Aug 30, 2024

BUY
$69.84 - $81.59 $71,376 - $83,384
1,022 Added 0.77%
133,892 $11.2 Billion
Q1 2019

Aug 30, 2024

SELL
$69.58 - $79.36 $442,737 - $504,967
-6,363 Reduced 4.57%
132,870 $11.1 Billion
Q4 2018

Aug 30, 2024

SELL
$65.24 - $75.71 $6.88 Million - $7.98 Million
-105,461 Reduced 43.1%
139,233 $10.6 Billion
Q3 2018

Aug 30, 2024

SELL
$57.69 - $67.84 $294,045 - $345,780
-5,097 Reduced 3.34%
147,636 $10.5 Billion
Q2 2018

Aug 30, 2024

SELL
$50.83 - $59.72 $35,835 - $42,102
-705 Reduced 0.46%
152,733 $9.27 Billion
Q1 2018

Aug 30, 2024

BUY
$50.96 - $59.23 $244,709 - $284,422
4,802 Added 3.23%
153,438 $8.36 Billion
Q4 2017

Aug 30, 2024

BUY
$51.62 - $61.64 $1.64 Million - $1.95 Million
31,700 Added 27.11%
148,636 $8.36 Billion
Q3 2017

Aug 30, 2024

BUY
$58.67 - $63.13 $113,467 - $122,093
1,934 Added 1.68%
116,936 $7.49 Billion
Q2 2017

Aug 30, 2024

BUY
N/A
95,693 Added 495.59%
115,002 $7.37 Billion
Q1 2017

Aug 30, 2024

SELL
N/A
-225,385
19,309 $1.23 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.